ReviewFrontiers in pharmacology2022

Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules.

Andrey D Bondarev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.